triple agonist glp 1 Agonism Based Therapies for Obesity retatrutide triple agonist glp-1 gip

Practice Pearls: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral drugs for type 2 diabetes that inhibit the breakdown of glucagon-like peptide-1 (GLP-1) and increase the release of insulin in response to a meal

[3-5],[60-65] The most common side effects of GLP-1RA are gastrointestinal (nausea, vomiting, diarrhea)

Bariatric Surgery Bariatric surgery remains the most aggressive intervention for severe obesity, but GLP-1 medications now deliver results that approach surgical outcomes without the operating room

Before using it, discuss benefits and risks with your healthcare provider

What Testing Reveals Over Time Single snapshots miss the full picture

Dietary Changes: Protein First: You must prioritize protein intake to protect your muscle mass as you lose weight